Akari Therapeutics (AKTX)
NASDAQ: AKTX
· Real-Time Price · USD
0.99
0.02 (2.05%)
At close: Aug 15, 2025, 2:28 PM
2.05% (1D)
| Bid | 0.98 |
| Market Cap | 16.01K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -17.93M |
| EPS (ttm) | -2.58 |
| PE Ratio (ttm) | -0.39 |
| Forward PE | -2.16 |
| Analyst | Buy |
| Ask | 1.02 |
| Volume | 38,261 |
| Avg. Volume (20D) | 26,140 |
| Open | 1.01 |
| Previous Close | 0.97 |
| Day's Range | 0.97 - 1.05 |
| 52-Week Range | 0.85 - 4.22 |
| Beta | 0.23 |
About AKTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AKTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+20%
Akari Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
